We report a new pH and enzyme dual responsive biodegradable polymer nanocarrier to deliver multiple anticancer drugs at the intracellular compartment in cancer cells. Natural L-aspartic acid was converted into multifunctional monomer and polymerized to yield new classes of biodegradable aliphatic polyester in-build with pH responsiveness. The transformation of side chain BOC urethanes into cationic NH 1 3 in the acidic endosomal environment disassembled the polymers nanoparticles (pH trigger-1). The biodegradation of aliphatic polyester backbone by esterase enzyme ruptured the nanoassemblies and released the drugs in the cytoplasm (trigger-2). The polymer scaffolds were capable of delivering multiple drugs such as doxorubicin, topotecan, and curcumin (CUR). The cytotoxicity of the nascent and drug-loaded nanoparticles were tested in cervical (HeLa) and breast (MCF-7) cancer cell lines. The nascent polymer nanoscaffolds were found to be nontoxic to cells whereas their drug-loaded nanoparticles exhibited excellent killing. Confocal microscopic images revealed that the drug-loaded polymer nanoparticles were taken up by the cells and the dual degradation process delivered the drugs to nucleus and established the proof-of-concept. The present investigation opens up new platform for L-amino acid based polyester scaffolds, for the first time, in the intracellular drug delivery in cancer treatment.their monomer constituents from un-natural resources. Hence, it would be more appropriate to design biodegradable polymer nanocarriers based on biological monomer resources for cancer treatment and biomedical applications. Among the natural resources, L-amino acids are particularly interesting since their sequence and structure control the three dimensional assemblies of proteins and their enzymatic action in biological system. 24,25 L-Amino acid based synthetic amphiphilic oligopeptides 26 and diblock polypeptides 27-30 were tailor-made and their supramolecular nanoscaffolds were employed for tissue engineering, 31,32 drug and gene delivery, 33,34 etc. Unfortunately, these synthetic peptides were known to encounter difficulty for biodegradation at the intracellular level. 35 Digestive enzymes such as a-chymotrypsin and trypsin (available in intestine) were found to be highly specific in action to cleave peptide sequences in proteins. For example, a-chymotrypsinenzyme selectively cleaves C-terminal of phenyl alanine, tyrosine and tryptophan peptide linkages 36-38 whereas trypsinenzyme cleaves the C-terminal of arginine and lysine in peptides. 7 Hence, it is very difficult to predict or programme the enzymatic biodegradation of synthetic polypeptides in drug Additional Supporting Information may be found in the online version of this article.